Arrowhead Pharmaceuticals Inc (ARWR) Insider Trading
- $301,336.35
- $142,943,488.14
- May 2, 2024
- Christopher Richard Anzalone
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
May 2, 2024 | Director | 1,799 | $23.31 | Sell | $41,934.69 | |
March 20, 2024 | Director | 1,000 | $27.50 | Buy | $27,500.00 | |
March 18, 2024 | Director | 1,000 | $27.49 | Buy | $27,490.00 | |
March 6, 2024 | CFO | 40,000 | $35.19 | Sell | $1,407,600.00 | |
Jan. 31, 2024 | CEO | 57,499 | $32.35 | Sell | $1,860,092.65 | |
Jan. 12, 2024 | Insider | 7,940 | $36.89 | Sell | $292,906.60 | |
Jan. 11, 2024 | Director | 2,911 | $38.06 | Sell | $110,792.66 | |
Jan. 5, 2024 | Insider | 32,143 | $35.18 | Sell | $1,130,790.74 | |
Jan. 5, 2024 | COO | 22,841 | $35.27 | Sell | $805,602.07 | |
Jan. 5, 2024 | CFO | 16,104 | $35.27 | Sell | $567,988.08 | |
Jan. 3, 2024 | Insider | 6,300 | $32.19 | Sell | $202,797.00 | |
Jan. 3, 2024 | COO | 8,749 | $32.28 | Sell | $282,417.72 | |
Jan. 2, 2024 | CEO | 9,952 | $31.01 | Sell | $308,611.52 | |
Dec. 20, 2023 | CEO | 12,000 | $28.54 | Sell | $342,480.00 | |
Nov. 20, 2023 | Insider | 19,700 | $28.80 | Sell | $567,360.00 | |
Oct. 25, 2023 | CEO | 24,338 | $24.21 | Sell | $589,222.98 | |
Sept. 28, 2023 | Director | 1,550 | $26.33 | Sell | $40,811.50 | |
Sept. 18, 2023 | CEO | 57,755 | $28.12 | Sell | $1,624,070.60 | |
July 3, 2023 | Insider | 8,925 | $35.31 | Sell | $315,141.75 | |
June 30, 2023 | Insider | 3,000 | $35.53 | Sell | $106,590.00 | |
June 27, 2023 | CFO | 15,000 | $36.20 | Sell | $543,000.00 | |
May 5, 2023 | Director | 6,500 | $40.90 | Sell | $265,850.00 | |
May 3, 2023 | CEO | 54,928 | $39.14 | Sell | $2,149,881.92 | |
March 3, 2023 | Director | 11,350 | $32.65 | Sell | $370,577.50 | |
Feb. 27, 2023 | Director | 875 | $32.62 | Sell | $28,542.50 | |
Jan. 9, 2023 | Director | 3,200 | $30.00 | Sell | $96,000.00 | |
Jan. 5, 2023 | COO | 15,000 | $37.39 | Sell | $560,850.00 | |
Jan. 5, 2023 | Insider | 13,803 | $37.40 | Sell | $516,232.20 | |
Jan. 3, 2023 | COO | 17,500 | $38.33 | Sell | $670,775.00 | |
Jan. 3, 2023 | Insider | 10,338 | $38.38 | Sell | $396,772.44 | |
Dec. 29, 2022 | CFO | 30,625 | $40.00 | Sell | $1,225,000.00 | |
Nov. 21, 2022 | Insider | 19,500 | $29.99 | Sell | $584,805.00 | |
Feb. 11, 2022 | CEO | 146,388 | $51.91 | Sell | $7,599,001.08 | |
Jan. 5, 2022 | General Counsel | 32,500 | $61.72 | Sell | $2,005,900.00 | |
Jan. 5, 2022 | CFO | 40,000 | $61.70 | Sell | $2,468,000.00 | |
Jan. 4, 2022 | SVP | 19,375 | $65.49 | Sell | $1,268,868.75 | |
Jan. 3, 2022 | Director | 4,500 | $64.72 | Sell | $291,240.00 | |
Dec. 28, 2021 | Director | 655 | $66.37 | Buy | $43,472.35 | |
Dec. 15, 2021 | CEO | 60,000 | $67.56 | Sell | $4,053,600.00 | |
Nov. 19, 2021 | Insider | 19,500 | $69.31 | Sell | $1,351,545.00 | |
Oct. 22, 2021 | CEO | 50,000 | $65.63 | Sell | $3,281,500.00 | |
Oct. 20, 2021 | CEO | 15,000 | $66.23 | Sell | $993,450.00 | |
Sept. 13, 2021 | Director | 5,000 | $63.76 | Sell | $318,800.00 | |
June 24, 2021 | Director | 5,000 | $89.85 | Sell | $449,250.00 | |
June 22, 2021 | Insider | 3,625 | $89.22 | Sell | $323,422.50 | |
June 22, 2021 | Director | 4,500 | $89.21 | Sell | $401,445.00 | |
Feb. 8, 2021 | General Counsel | 90,000 | $88.46 | Sell | $7,961,400.00 | |
Jan. 15, 2021 | Director | 3,000 | $83.28 | Sell | $249,840.00 | |
Jan. 14, 2021 | SVP | 10,000 | $81.29 | Sell | $812,900.00 | |
Jan. 12, 2021 | CFO | 13,038 | $81.02 | Sell | $1,056,338.76 |
Insiders are both buying and selling Arrowhead Pharmaceuticals Inc stock.
The insider traders at Arrowhead Pharmaceuticals Inc are: Christopher Richard Anzalone, Kenneth Allen Myszkowski, Bruce D Given, Patrick O'brien, Douglas B Given, James C Hamilton, Douglas B. Given, Backer Marianne De, Martin Javier San, William D Waddill, Mauro Ferrari, Michael S Perry, Adeoye Y Olukotun, Charles Mckenney, David L Lewis, Hongbo Lu, James Hassard, Victoria Vakiener, Tracie Oliver, Zhen Li, Edward W Frykman, and Peter Brian Leone
The most active insider trader at Arrowhead Pharmaceuticals Inc is Christopher Richard Anzalone with 28 trades.
Christopher Richard Anzalone has sold the most Arrowhead Pharmaceuticals Inc stock with a total value of $63,729,086.06.
Christopher Richard Anzalone has bought the most Arrowhead Pharmaceuticals Inc stock with a total value of $202,240.00.
The most recent insider trade for Arrowhead Pharmaceuticals Inc was on May 2, 2024.
The single biggest insider buy for Arrowhead Pharmaceuticals Inc was from Christopher Richard Anzalone with a total value of $101,120.00 on Oct. 15, 2014.
The single biggest insider sell for Arrowhead Pharmaceuticals Inc was from Patrick O'brien with a total value of $7,961,400.00 on Feb. 8, 2021.